← Back to Sector Map

ALGN

Health Care · Health Care Supplies

ALIGN TECHNOLOGY INC

$176.37

+1.25%

AI Research

Barclays upgrades to Overweight with $200 target; Q4 record revenue $1.05B beats estimates

PositiveBuyPT $200.00

Align Technology was upgraded by Barclays from Equal Weight to Overweight with a $200 price target on March 17, 2026, suggesting 18% upside from the previous close. Q4 2025 showed record total revenue of $1,047.6M (+5.3% YoY) and record clear aligner shipments of 676.9K cases, with EPS of $3.29 beating the $2.99 estimate. The company guides 2026 revenue growth of 3%-4%; 7 analysts rate Buy and 7 Hold, with a "Moderate Buy" consensus and $198.08 average target.

Key Stats

Market Cap$12.2B
P/E (TTM)30.0
Fwd P/E13.8
Beta1.82
Div Yield
Prev Close$174.19

52-Week Range

$122.00$176.37$208.31